maximum strength acid reducer

Generic: famotidine

Labeler: target corporation
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name maximum strength acid reducer
Generic Name famotidine
Labeler target corporation
Dosage Form TABLET
Routes
ORAL
Active Ingredients

famotidine 20 mg/1

Manufacturer
TARGET CORPORATION

Identifiers & Regulatory

Product NDC 11673-697
Product ID 11673-697_18567eaf-6b97-8c6f-e063-6294a90a986d
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA217543
Listing Expiration 2026-12-31
Marketing Start 2024-05-15

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 11673697
Hyphenated Format 11673-697

Supplemental Identifiers

RxCUI
310273
UNII
5QZO15J2Z8
NUI
N0000000151 N0000175784

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name maximum strength acid reducer (source: ndc)
Generic Name famotidine (source: ndc)
Application Number ANDA217543 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 2 BOTTLE in 1 CARTON (11673-697-01) / 50 TABLET in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (11673-697-05) / 50 TABLET in 1 BOTTLE
  • 1 BOTTLE in 1 CARTON (11673-697-20) / 200 TABLET in 1 BOTTLE
  • 5 BLISTER PACK in 1 CARTON (11673-697-52) / 5 TABLET in 1 BLISTER PACK
source: ndc

Packages (4)

11673-697-01 2 BOTTLE in 1 CARTON (11673-697-01) / 50 TABLET in 1 BOTTLE 11673-697-05 1 BOTTLE in 1 CARTON (11673-697-05) / 50 TABLET in 1 BOTTLE 11673-697-20 1 BOTTLE in 1 CARTON (11673-697-20) / 200 TABLET in 1 BOTTLE 11673-697-52 5 BLISTER PACK in 1 CARTON (11673-697-52) / 5 TABLET in 1 BLISTER PACK

Ingredients (1)

famotidine (20 mg/1)

Linked Drug Pages (1)

Maximum Strength Acid Reducer ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "18567eaf-6b97-8c6f-e063-6294a90a986d", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["5QZO15J2Z8"], "rxcui": ["310273"], "spl_set_id": ["07a924f1-14cc-4e7d-e063-6394a90ac7f3"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["TARGET CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BOTTLE in 1 CARTON (11673-697-01)  / 50 TABLET in 1 BOTTLE", "package_ndc": "11673-697-01", "marketing_start_date": "20240515"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-697-05)  / 50 TABLET in 1 BOTTLE", "package_ndc": "11673-697-05", "marketing_start_date": "20240515"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-697-20)  / 200 TABLET in 1 BOTTLE", "package_ndc": "11673-697-20", "marketing_start_date": "20240515"}, {"sample": false, "description": "5 BLISTER PACK in 1 CARTON (11673-697-52)  / 5 TABLET in 1 BLISTER PACK", "package_ndc": "11673-697-52", "marketing_start_date": "20240515"}], "brand_name": "Maximum Strength Acid Reducer", "product_id": "11673-697_18567eaf-6b97-8c6f-e063-6294a90a986d", "dosage_form": "TABLET", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "11673-697", "generic_name": "Famotidine", "labeler_name": "TARGET CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Maximum Strength Acid Reducer", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "20 mg/1"}], "application_number": "ANDA217543", "marketing_category": "ANDA", "marketing_start_date": "20240515", "listing_expiration_date": "20261231"}